$2.15 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 113 reported holdings in Q3 2013. The portfolio turnover from Q2 2013 to Q3 2013 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| THOR | New | THORATEC CORP | $33,225,000 | – | 891,000 | +100.0% | 1.54% | – |
| MYL | New | MYLAN INC | $29,696,000 | – | 778,000 | +100.0% | 1.38% | – |
| MNTA | New | MOMENTA PHARMACEUTICALS INC | $28,893,000 | – | 2,007,886 | +100.0% | 1.34% | – |
| ONTX | New | ONCONOVA THERAPEUTICS INC | $25,615,000 | – | 967,696 | +100.0% | 1.19% | – |
| CSU | New | CAPITAL SR LIVING CORP | $22,221,000 | – | 1,050,648 | +100.0% | 1.03% | – |
| RNA | New | PROSENSA HLDG N V | $21,314,000 | – | 3,224,524 | +100.0% | 0.99% | – |
| GMED | New | GLOBUS MED INCcl a | $20,913,000 | – | 1,197,765 | +100.0% | 0.97% | – |
| PTCT | New | PTC THERAPEUTICS INC | $18,134,000 | – | 845,027 | +100.0% | 0.84% | – |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDcall | $13,223,000 | – | 350,000 | +100.0% | 0.62% | – |
| BCRX | New | BIOCRYST PHARMACEUTICALS | $11,884,000 | – | 1,632,360 | +100.0% | 0.55% | – |
| BLUE | New | BLUEBIRD BIO INC | $11,410,000 | – | 423,224 | +100.0% | 0.53% | – |
| BIOS | New | BIOSCRIP INC | $10,967,000 | – | 1,249,041 | +100.0% | 0.51% | – |
| NSPH | New | NANOSPHERE INC | $10,286,000 | – | 5,143,219 | +100.0% | 0.48% | – |
| VNDA | New | VANDA PHARMACEUTICALS INC | $8,979,000 | – | 820,000 | +100.0% | 0.42% | – |
| ANTH | New | ANTHERA PHARMACEUTICALS INC | $6,801,000 | – | 1,691,857 | +100.0% | 0.32% | – |
| MYL | New | MYLAN INCcall | $5,726,000 | – | 150,000 | +100.0% | 0.27% | – |
| NSTG | New | NANOSTRING TECHNOLOGIES INC | $5,463,000 | – | 496,650 | +100.0% | 0.25% | – |
| AIRM | New | AIR METHODS CORPcall | $5,320,000 | – | 125,000 | +100.0% | 0.25% | – |
| SRPT | New | SAREPTA THERAPEUTICS INCput | $4,723,000 | – | 100,000 | +100.0% | 0.22% | – |
| CASM | New | CAS MED SYS INC | $4,288,000 | – | 3,200,000 | +100.0% | 0.20% | – |
| AGIO | New | AGIOS PHARMACEUTICALS INC | $4,223,000 | – | 151,050 | +100.0% | 0.20% | – |
| ESRX | New | EXPRESS SCRIPTS HLDG CO | $4,017,000 | – | 65,000 | +100.0% | 0.19% | – |
| TXMD | New | THERAPEUTICSMD INC | $3,663,000 | – | 1,250,000 | +100.0% | 0.17% | – |
| NVAX | New | NOVAVAX INC | $3,392,000 | – | 1,076,980 | +100.0% | 0.16% | – |
| GEVA | New | SYNAGEVA BIOPHARMA CORP | $3,170,000 | – | 50,000 | +100.0% | 0.15% | – |
| SQNM | New | SEQUENOM INC | $2,630,000 | – | 985,000 | +100.0% | 0.12% | – |
| GTXI | New | GTX INC DELcall | $1,013,000 | – | 500,000 | +100.0% | 0.05% | – |
| BAX | New | BAXTER INTL INC | $985,000 | – | 15,000 | +100.0% | 0.05% | – |
| AVNR | New | AVANIR PHARMACEUTICALS INCcl a new | $656,000 | – | 155,000 | +100.0% | 0.03% | – |
| SPHS | New | SOPHIRIS BIO INC | $578,000 | – | 123,585 | +100.0% | 0.03% | – |
| BRKR | New | BRUKER CORP | $434,000 | – | 21,000 | +100.0% | 0.02% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2013-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-06-14 |
| 4 | 2024-06-03 |
| 13F-HR | 2024-05-15 |
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.